Formycon AG header image

Formycon AG

FYB

Equity

ISIN DE000A1EWVY8 / Valor 12194189

Xetra (2026-09-04)
EUR 20.50+0.49%

Formycon AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Formycon AG is a prominent independent developer specializing in biosimilars, which are biologic drugs designed to be highly similar to already approved biopharmaceutical medicines. The company focuses on creating treatments primarily in the fields of ophthalmology and immunology, as well as addressing other significant chronic diseases. Formycon's operations encompass the entire development process, from technical and pharmaceutical development to conducting clinical trials, and preparing and submitting regulatory approval dossiers. By developing biosimilars, Formycon aims to enhance patient access to essential medications, ensuring that these follow-on products maintain the same quality, efficacy, and safety as their reference counterparts.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-11.4%1Y
-65.9%3Y
-62.7%5Y

Performance

50.2%1Y
52.6%3Y
49.8%5Y

Volatility

Market cap

421 M

Market cap (USD)

Daily traded volume (Shares)

5,451

Daily traded volume (Shares)

1 day high/low

53.2 / 51

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Mankind Pharma Ltd.
Mankind Pharma Ltd. Mankind Pharma Ltd. Valor: 126566338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.70%INR 2,328.55
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.33%SEK 272.20
Lifco Ab
Lifco Ab Lifco Ab Valor: 111355378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.38%SEK 314.20
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Valor: 2676862
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.13%SEK 454.80
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.03%USD 15.30
Baxter International Inc
Baxter International Inc Baxter International Inc Valor: 911702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.02%USD 25.83
Dr. Agarwal's Health Care Ltd.
Dr. Agarwal's Health Care Ltd. Dr. Agarwal's Health Care Ltd. Valor: 141717620
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.31%INR 514.15
Indivior PLC
Indivior PLC Indivior PLC Valor: 121550831
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.35%GBP 25.85
Vitrolife AB
Vitrolife AB Vitrolife AB Valor: 41707777
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.50%SEK 95.00
Elekta AB
Elekta AB Elekta AB Valor: 613625
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.32%SEK 52.30